Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression
Inherited cardiomyopathy associates with a range of phenotypes, mediated by genetic and nongenetic factors. Noninherited cardiomyopathy also displays varying progression and outcomes. Expression of cardiomyopathy genes is under the regulatory control of promoters and enhancers, and human genetic var...
Gespeichert in:
Veröffentlicht in: | Circulation (New York, N.Y.) N.Y.), 2021-03, Vol.143 (13), p.1302-1316 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1316 |
---|---|
container_issue | 13 |
container_start_page | 1302 |
container_title | Circulation (New York, N.Y.) |
container_volume | 143 |
creator | Gacita, Anthony M. Fullenkamp, Dominic E. Ohiri, Joyce Pottinger, Tess Puckelwartz, Megan J. Nobrega, Marcelo A. McNally, Elizabeth M. |
description | Inherited cardiomyopathy associates with a range of phenotypes, mediated by genetic and nongenetic factors. Noninherited cardiomyopathy also displays varying progression and outcomes. Expression of cardiomyopathy genes is under the regulatory control of promoters and enhancers, and human genetic variation in promoters and enhancers may contribute to this variability.
We superimposed epigenomic profiling from hearts and cardiomyocytes, including promoter-capture chromatin conformation information, to identify enhancers for 2 cardiomyopathy genes,
and
. Enhancer function was validated in human cardiomyocytes derived from induced pluripotent stem cells. We also conducted a genome-wide search to ascertain genomic variation in enhancers positioned to alter cardiac expression and correlated one of these variants to cardiomyopathy progression using biobank data.
Multiple enhancers were identified and validated for
and
, including a key enhancer that regulates the switch from
expression to
expression. Deletion of this enhancer resulted in a dose-dependent increase in
and faster contractile rate in engineered heart tissues. We searched for genomic variation in enhancer sequences across the genome, with a focus on nucleotide changes that create or interrupt transcription factor binding sites. The sequence variant, rs875908, disrupts a T-Box Transcription Factor 5 binding motif and maps to an enhancer region 2 kilobases from the transcriptional start site of
Gene editing to remove the enhancer that harbors this variant markedly reduced
expression in human cardiomyocytes. Using biobank-derived data, rs875908 associated with longitudinal echocardiographic features of cardiomyopathy.
Enhancers regulate cardiomyopathy gene expression, and genomic variation within these enhancer regions associates with cardiomyopathic progression over time. This integrated approach identified noncoding modifiers of cardiomyopathy and is applicable to other cardiac genes. |
doi_str_mv | 10.1161/CIRCULATIONAHA.120.050432 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8009836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2480403810</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5905-d49ff3c2455047ab24d4c6f56cd0d2440a95c7f69378895037b9650fab1ec2273</originalsourceid><addsrcrecordid>eNpVkV9P2zAUxS20aXRsXwFlb3tJuf4Xxy-TqqhApQLTBLxaruMQb6nd2elYv_1ctUPwZF37nOOj-0PoC4YpxhW-aBY_mofl7H5xdzu7nk0xgSlwYJScoAnmhJWMU_kOTQBAloIScoo-pvQzjxUV_AM6pZSJmjA5QY9X1tvRmeJRR6dHF3zhfDH3vfbGxlTchNZ1zqai0bF1Yb0LGz32u2JvK-Z_N9GmtDdp3xbfY3g6zp_Q-04PyX4-nmfo4XJ-31yXy7urRTNbloZL4GXLZNdRQxjP9YVeEdYyU3W8Mi20hDHQkhvRVZKKupYcqFjJikOnV9gaQgQ9Q98OuZvtam1bY_0Y9aA20a113KmgnXr74l2vnsIfVefV1LTKAV-PATH83to0qrVLxg6D9jZskyKsBga0xpCl8iA1MaQUbffyDQa156LeclGZizpwyd7z1z1fnP9BZAE7CJ7DMObF_xq2zzaq3uph7FUmBxSwKAmQ3IQClPsrTv8BRHabtQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2480403810</pqid></control><display><type>article</type><title>Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete - AutoHoldings</source><creator>Gacita, Anthony M. ; Fullenkamp, Dominic E. ; Ohiri, Joyce ; Pottinger, Tess ; Puckelwartz, Megan J. ; Nobrega, Marcelo A. ; McNally, Elizabeth M.</creator><creatorcontrib>Gacita, Anthony M. ; Fullenkamp, Dominic E. ; Ohiri, Joyce ; Pottinger, Tess ; Puckelwartz, Megan J. ; Nobrega, Marcelo A. ; McNally, Elizabeth M.</creatorcontrib><description>Inherited cardiomyopathy associates with a range of phenotypes, mediated by genetic and nongenetic factors. Noninherited cardiomyopathy also displays varying progression and outcomes. Expression of cardiomyopathy genes is under the regulatory control of promoters and enhancers, and human genetic variation in promoters and enhancers may contribute to this variability.
We superimposed epigenomic profiling from hearts and cardiomyocytes, including promoter-capture chromatin conformation information, to identify enhancers for 2 cardiomyopathy genes,
and
. Enhancer function was validated in human cardiomyocytes derived from induced pluripotent stem cells. We also conducted a genome-wide search to ascertain genomic variation in enhancers positioned to alter cardiac expression and correlated one of these variants to cardiomyopathy progression using biobank data.
Multiple enhancers were identified and validated for
and
, including a key enhancer that regulates the switch from
expression to
expression. Deletion of this enhancer resulted in a dose-dependent increase in
and faster contractile rate in engineered heart tissues. We searched for genomic variation in enhancer sequences across the genome, with a focus on nucleotide changes that create or interrupt transcription factor binding sites. The sequence variant, rs875908, disrupts a T-Box Transcription Factor 5 binding motif and maps to an enhancer region 2 kilobases from the transcriptional start site of
Gene editing to remove the enhancer that harbors this variant markedly reduced
expression in human cardiomyocytes. Using biobank-derived data, rs875908 associated with longitudinal echocardiographic features of cardiomyopathy.
Enhancers regulate cardiomyopathy gene expression, and genomic variation within these enhancer regions associates with cardiomyopathic progression over time. This integrated approach identified noncoding modifiers of cardiomyopathy and is applicable to other cardiac genes.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/CIRCULATIONAHA.120.050432</identifier><identifier>PMID: 33478249</identifier><language>eng</language><publisher>United States: Lippincott Williams & Wilkins</publisher><subject>Cardiac Myosins - metabolism ; Cardiomyopathies - genetics ; Disease Progression ; Gene Expression - genetics ; Genetic Variation - genetics ; Humans ; Myosin Heavy Chains - metabolism ; Promoter Regions, Genetic - genetics</subject><ispartof>Circulation (New York, N.Y.), 2021-03, Vol.143 (13), p.1302-1316</ispartof><rights>Lippincott Williams & Wilkins</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5905-d49ff3c2455047ab24d4c6f56cd0d2440a95c7f69378895037b9650fab1ec2273</citedby><cites>FETCH-LOGICAL-c5905-d49ff3c2455047ab24d4c6f56cd0d2440a95c7f69378895037b9650fab1ec2273</cites><orcidid>0000-0002-0455-2983 ; 0000-0002-2134-9661 ; 0000-0002-1221-719X ; 0000-0001-7627-7119</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,778,782,883,3676,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33478249$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gacita, Anthony M.</creatorcontrib><creatorcontrib>Fullenkamp, Dominic E.</creatorcontrib><creatorcontrib>Ohiri, Joyce</creatorcontrib><creatorcontrib>Pottinger, Tess</creatorcontrib><creatorcontrib>Puckelwartz, Megan J.</creatorcontrib><creatorcontrib>Nobrega, Marcelo A.</creatorcontrib><creatorcontrib>McNally, Elizabeth M.</creatorcontrib><title>Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>Inherited cardiomyopathy associates with a range of phenotypes, mediated by genetic and nongenetic factors. Noninherited cardiomyopathy also displays varying progression and outcomes. Expression of cardiomyopathy genes is under the regulatory control of promoters and enhancers, and human genetic variation in promoters and enhancers may contribute to this variability.
We superimposed epigenomic profiling from hearts and cardiomyocytes, including promoter-capture chromatin conformation information, to identify enhancers for 2 cardiomyopathy genes,
and
. Enhancer function was validated in human cardiomyocytes derived from induced pluripotent stem cells. We also conducted a genome-wide search to ascertain genomic variation in enhancers positioned to alter cardiac expression and correlated one of these variants to cardiomyopathy progression using biobank data.
Multiple enhancers were identified and validated for
and
, including a key enhancer that regulates the switch from
expression to
expression. Deletion of this enhancer resulted in a dose-dependent increase in
and faster contractile rate in engineered heart tissues. We searched for genomic variation in enhancer sequences across the genome, with a focus on nucleotide changes that create or interrupt transcription factor binding sites. The sequence variant, rs875908, disrupts a T-Box Transcription Factor 5 binding motif and maps to an enhancer region 2 kilobases from the transcriptional start site of
Gene editing to remove the enhancer that harbors this variant markedly reduced
expression in human cardiomyocytes. Using biobank-derived data, rs875908 associated with longitudinal echocardiographic features of cardiomyopathy.
Enhancers regulate cardiomyopathy gene expression, and genomic variation within these enhancer regions associates with cardiomyopathic progression over time. This integrated approach identified noncoding modifiers of cardiomyopathy and is applicable to other cardiac genes.</description><subject>Cardiac Myosins - metabolism</subject><subject>Cardiomyopathies - genetics</subject><subject>Disease Progression</subject><subject>Gene Expression - genetics</subject><subject>Genetic Variation - genetics</subject><subject>Humans</subject><subject>Myosin Heavy Chains - metabolism</subject><subject>Promoter Regions, Genetic - genetics</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkV9P2zAUxS20aXRsXwFlb3tJuf4Xxy-TqqhApQLTBLxaruMQb6nd2elYv_1ctUPwZF37nOOj-0PoC4YpxhW-aBY_mofl7H5xdzu7nk0xgSlwYJScoAnmhJWMU_kOTQBAloIScoo-pvQzjxUV_AM6pZSJmjA5QY9X1tvRmeJRR6dHF3zhfDH3vfbGxlTchNZ1zqai0bF1Yb0LGz32u2JvK-Z_N9GmtDdp3xbfY3g6zp_Q-04PyX4-nmfo4XJ-31yXy7urRTNbloZL4GXLZNdRQxjP9YVeEdYyU3W8Mi20hDHQkhvRVZKKupYcqFjJikOnV9gaQgQ9Q98OuZvtam1bY_0Y9aA20a113KmgnXr74l2vnsIfVefV1LTKAV-PATH83to0qrVLxg6D9jZskyKsBga0xpCl8iA1MaQUbffyDQa156LeclGZizpwyd7z1z1fnP9BZAE7CJ7DMObF_xq2zzaq3uph7FUmBxSwKAmQ3IQClPsrTv8BRHabtQ</recordid><startdate>20210330</startdate><enddate>20210330</enddate><creator>Gacita, Anthony M.</creator><creator>Fullenkamp, Dominic E.</creator><creator>Ohiri, Joyce</creator><creator>Pottinger, Tess</creator><creator>Puckelwartz, Megan J.</creator><creator>Nobrega, Marcelo A.</creator><creator>McNally, Elizabeth M.</creator><general>Lippincott Williams & Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0455-2983</orcidid><orcidid>https://orcid.org/0000-0002-2134-9661</orcidid><orcidid>https://orcid.org/0000-0002-1221-719X</orcidid><orcidid>https://orcid.org/0000-0001-7627-7119</orcidid></search><sort><creationdate>20210330</creationdate><title>Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression</title><author>Gacita, Anthony M. ; Fullenkamp, Dominic E. ; Ohiri, Joyce ; Pottinger, Tess ; Puckelwartz, Megan J. ; Nobrega, Marcelo A. ; McNally, Elizabeth M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5905-d49ff3c2455047ab24d4c6f56cd0d2440a95c7f69378895037b9650fab1ec2273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cardiac Myosins - metabolism</topic><topic>Cardiomyopathies - genetics</topic><topic>Disease Progression</topic><topic>Gene Expression - genetics</topic><topic>Genetic Variation - genetics</topic><topic>Humans</topic><topic>Myosin Heavy Chains - metabolism</topic><topic>Promoter Regions, Genetic - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gacita, Anthony M.</creatorcontrib><creatorcontrib>Fullenkamp, Dominic E.</creatorcontrib><creatorcontrib>Ohiri, Joyce</creatorcontrib><creatorcontrib>Pottinger, Tess</creatorcontrib><creatorcontrib>Puckelwartz, Megan J.</creatorcontrib><creatorcontrib>Nobrega, Marcelo A.</creatorcontrib><creatorcontrib>McNally, Elizabeth M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gacita, Anthony M.</au><au>Fullenkamp, Dominic E.</au><au>Ohiri, Joyce</au><au>Pottinger, Tess</au><au>Puckelwartz, Megan J.</au><au>Nobrega, Marcelo A.</au><au>McNally, Elizabeth M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2021-03-30</date><risdate>2021</risdate><volume>143</volume><issue>13</issue><spage>1302</spage><epage>1316</epage><pages>1302-1316</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><abstract>Inherited cardiomyopathy associates with a range of phenotypes, mediated by genetic and nongenetic factors. Noninherited cardiomyopathy also displays varying progression and outcomes. Expression of cardiomyopathy genes is under the regulatory control of promoters and enhancers, and human genetic variation in promoters and enhancers may contribute to this variability.
We superimposed epigenomic profiling from hearts and cardiomyocytes, including promoter-capture chromatin conformation information, to identify enhancers for 2 cardiomyopathy genes,
and
. Enhancer function was validated in human cardiomyocytes derived from induced pluripotent stem cells. We also conducted a genome-wide search to ascertain genomic variation in enhancers positioned to alter cardiac expression and correlated one of these variants to cardiomyopathy progression using biobank data.
Multiple enhancers were identified and validated for
and
, including a key enhancer that regulates the switch from
expression to
expression. Deletion of this enhancer resulted in a dose-dependent increase in
and faster contractile rate in engineered heart tissues. We searched for genomic variation in enhancer sequences across the genome, with a focus on nucleotide changes that create or interrupt transcription factor binding sites. The sequence variant, rs875908, disrupts a T-Box Transcription Factor 5 binding motif and maps to an enhancer region 2 kilobases from the transcriptional start site of
Gene editing to remove the enhancer that harbors this variant markedly reduced
expression in human cardiomyocytes. Using biobank-derived data, rs875908 associated with longitudinal echocardiographic features of cardiomyopathy.
Enhancers regulate cardiomyopathy gene expression, and genomic variation within these enhancer regions associates with cardiomyopathic progression over time. This integrated approach identified noncoding modifiers of cardiomyopathy and is applicable to other cardiac genes.</abstract><cop>United States</cop><pub>Lippincott Williams & Wilkins</pub><pmid>33478249</pmid><doi>10.1161/CIRCULATIONAHA.120.050432</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-0455-2983</orcidid><orcidid>https://orcid.org/0000-0002-2134-9661</orcidid><orcidid>https://orcid.org/0000-0002-1221-719X</orcidid><orcidid>https://orcid.org/0000-0001-7627-7119</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-7322 |
ispartof | Circulation (New York, N.Y.), 2021-03, Vol.143 (13), p.1302-1316 |
issn | 0009-7322 1524-4539 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8009836 |
source | MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete - AutoHoldings |
subjects | Cardiac Myosins - metabolism Cardiomyopathies - genetics Disease Progression Gene Expression - genetics Genetic Variation - genetics Humans Myosin Heavy Chains - metabolism Promoter Regions, Genetic - genetics |
title | Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T15%3A31%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetic%20Variation%20in%20Enhancers%20Modifies%20Cardiomyopathy%20Gene%20Expression%20and%20Progression&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=Gacita,%20Anthony%20M.&rft.date=2021-03-30&rft.volume=143&rft.issue=13&rft.spage=1302&rft.epage=1316&rft.pages=1302-1316&rft.issn=0009-7322&rft.eissn=1524-4539&rft_id=info:doi/10.1161/CIRCULATIONAHA.120.050432&rft_dat=%3Cproquest_pubme%3E2480403810%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2480403810&rft_id=info:pmid/33478249&rfr_iscdi=true |